Becton Dickinson Operating Income 2010-2024 | BDX

Becton Dickinson annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Becton Dickinson operating income for the quarter ending March 31, 2024 was $0.734B, a 17.07% increase year-over-year.
  • Becton Dickinson operating income for the twelve months ending March 31, 2024 was $2.070B, a 7.55% decline year-over-year.
  • Becton Dickinson annual operating income for 2023 was $2.111B, a 7.53% decline from 2022.
  • Becton Dickinson annual operating income for 2022 was $2.283B, a 1.42% increase from 2021.
  • Becton Dickinson annual operating income for 2021 was $2.251B, a 146.82% increase from 2020.
Becton Dickinson Annual Operating Income
(Millions of US $)
2023 $2,111
2022 $2,283
2021 $2,251
2020 $912
2019 $1,760
2018 $1,509
2017 $1,522
2016 $1,430
2015 $1,074
2014 $1,606
2013 $1,255
2012 $1,558
2011 $1,665
2010 $1,582
2009 $1,590
Becton Dickinson Quarterly Operating Income
(Millions of US $)
2024-03-31 $734
2023-12-31 $438
2023-09-30 $351
2023-06-30 $547
2023-03-31 $627
2022-12-31 $586
2022-09-30 $489
2022-06-30 $537
2022-03-31 $566
2021-12-31 $691
2021-09-30 $84
2021-06-30 $492
2021-03-31 $433
2020-12-31 $1,242
2020-09-30 $-317
2020-06-30 $359
2020-03-31 $369
2019-12-31 $501
2019-09-30 $112
2019-06-30 $626
2019-03-31 $136
2018-12-31 $886
2018-09-30 $576
2018-06-30 $511
2018-03-31 $187
2017-12-31 $235
2017-09-30 $491
2017-06-30 $-224
2017-03-31 $445
2016-12-31 $810
2016-09-30 $97
2016-06-30 $516
2016-03-31 $465
2015-12-31 $352
2015-09-30 $295
2015-06-30 $137
2015-03-31 $293
2014-12-31 $349
2014-09-30 $401
2014-06-30 $446
2014-03-31 $381
2013-12-31 $378
2013-09-30 $77
2013-06-30 $405
2013-03-31 $381
2012-12-31 $392
2012-09-30 $389
2012-06-30 $449
2012-03-31 $383
2011-12-31 $337
2011-09-30 $364
2011-06-30 $447
2011-03-31 $440
2010-12-31 $413
2010-09-30 $316
2010-06-30 $423
2010-03-31 $414
2009-12-31 $430
2009-09-30 $379
2009-06-30 $432
2009-03-31 $361
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $67.549B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.372B 21.99
Cardinal Health (CAH) United States $25.353B 14.50
West Pharmaceutical Services (WST) United States $23.461B 42.05
Cooper (COO) United States $18.251B 26.92
Align Technology (ALGN) United States $18.233B 35.20
Labcorp (LH) United States $17.408B 14.98
Henry Schein (HSIC) United States $8.743B 15.55
DENTSPLY SIRONA (XRAY) United States $5.328B 13.80
Merit Medical Systems (MMSI) United States $4.726B 25.90
Patterson (PDCO) United States $2.274B 10.99
CONMED (CNMD) United States $2.078B 18.85
STAAR Surgical (STAA) United States $2.026B 77.79
Atrion (ATRI) United States $0.803B 42.87
Lifevantage (LFVN) United States $0.085B 10.97
Pro-Dex (PDEX) United States $0.065B 32.67
Biolase (BIOL) United States $0.004B 0.00